This year’s most-popular content on psoriasis include research regarding disparities and socioeconomic factors that impact psoriasis treatment and an interview on shared decision making.
The top 5 most-popular psoriasis content this year includes research into geographical differences in mortality, risk factors associated with psoriasis, and the importance of shared decision-making for better managing of this skin condition.
5. Dr Patrick Burnett on Shared Decision-Making for Moderate to Severe Psoriasis
Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discussed key clinical recommendations for patients with moderate to severe psoriasis with uncontrolled disease, stressing the importance of having a conversation with patients about their end-goal in treatment, focusing bettering their quality of life.
Burnett also discussed the importance of shared decision-making in treating patients with moderate to severe psoriasis.
4. Pulling Apart Methods of Diagnosing Axial Psoriatic Arthritis, Back Pain
Despite the high prevalence of axial disease among patients with psoriatic arthritis, disagreement on definitions caused difficulty in diagnosing axial spondylarthritis and back pain. Furthermore, the researchers of this study found notable differences when comparing psoriatic arthritis with ankylosing spondylitis in terms of intensity of back pain and mobility.
3. Study Highlights Wide Variation in Mortality of Spondyloarthritis, IBD Across the Globe
Large variations in mortality rates for spondylarthritis and inflammatory bowel disease were found geographically. These variations highlight different disparities and socioeconomic factors that may have affected mortality rates across different regions.
2. TNF Inhibitors Linked to Higher Risk of Psoriasis in Patients With IBD, RA
Researchers underscored the risk of new-onset psoriasis due to tumor necrosis factor-a (TNF) inhibitor. Patients with immune-mediated inflammatory diseases had a 2-fold risk of new-onset psoriasis, according to the study.
1. Study Finds Link Between Psoriasis, NAFLD Among US Adult Outpatients
One study found outpatients with psoriasis were at greater risk of developing nonalcoholic fatty liver disease (NAFLD) than those without the skin condition. These findings validated prior research on this subject matter, that had found psoriasis to be linked to several comorbid conditions, including cardiovascular diseases, diabetes, and NAFLD.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More